Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade Article Swipe

Adel Samson , Karen J. Scott , David J. Taggart , Emma J. West , Erica Wilson , Gerard J. Nuovo , Simon Thomson , Robert Corns , Ryan Mathew , Martin Fuller , Timothy Kottke , Jill Thompson , Elizabeth J. Ilett , Julia Cockle , Philip van Hille , Gnanamurthy Sivakumar , Euan S. Polson , Samantha Turnbull , Elizabeth Appleton , G Migneco , Ailsa Rose , Matthew Coffey , Deborah Beirne , Fiona Collinson , Christy Ralph , Alan Anthoney , Christopher Twelves , Andrew J.S. Furness , Sergio A. Quezada , Heiko Wurdak , Fiona Errington‐Mais , Hardev Pandha , Kevin J. Harrington , Peter J. Selby , Richard G. Vile , Stephen Griffin , Lucy F. Stead , Susan Short , Alan Melcher · YOU? · · 2018 · Open Access · · DOI: https://doi.org/10.1126/scitranslmed.aam7577 · OA: W2781931068